header image

Abstracts

Abstract submission will be available soon

Thank you for your interest in contributing to the program of the 23rd Human Proteome Organization World Congress. The abstract submission will be available from February 29.

Important dates

February 29, 2024 Abstract submission and registration open
May 31, 2024

Abstract submission deadline

The abstract deadline of May 31 will not be extended!
After this date, the system will be closed so that no more submissions can be considered.

June 2024 Abstract review
July 08, 2024 Abstract notifications
July 15, 2024 Early bird Registration deadline
August 15, 2024 Regular registration deadline

 

  • Cell Biology Insights
  • Chemical Biology Insights
  • Clinical Proteomics
  • Data Integration: With Bioinformatics to Biological Knowledge
  • Defining Signaling Networks - Functional PTMs
  • Glycobiology Insights
  • Human Health Insights (Neurobiology, Cardiovascular, Liver, Kidney etc.)
  • Immunopeptidomics
  • Infectious Biology Insights
  • Microbiology and Microbiome Analysis
  • Multiomics Approaches
  • New Technology: AI and Bioinformatics in Mass Spectrometry
  • New Technology: Chromatography
  • New Technology: MS-based Proteomics
  • New Technology: Non MS-based Proteomics
  • New Technology: Sample Preparation
  • One Health Approaches (Plant, Food, Nutrition, Animal, Environment)
  • Organisation of the Proteome (PPI)
  • Population Proteomics in Health and Disease
  • Spatial and Imaging Proteomics
  • Structural Proteomics
  • An abstract may have only one presenting author. There is no limit to the number of co-authors per abstract.
  • There is no fee for submitting an abstract
  • Prepare the following sections in plain English text for pasting into the appropriate text boxes during submission.
  • Abstracts can be edited after submission.

The abstract deadline of May 31 will not be extended!
After this date, the system will be closed so that no more submissions can be considered.

For deatailed submission guidelines click here

Contact to abstract management